Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome

Pediatric Transplantation

Volumn 13, Issue 6, 2009, Pages 760-765

  Gozdzik, Jolanta ^a   Czogala, Wojciech ^a   Skoczen, Szymon ^a   Krasowska Kwiecien, Aleksandra ^a   Wiecha, Oktawiusz ^a   Mordel, Anna ^a   Lesko, Ewa ^a   Majka, Marcin ^a   Kowalczyk, Danuta ^a   Zembala, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Allogeneic bone marrow transplantation; Cytomegalovirus infection; Omenn syndrome; Reduced intensity conditioning

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; FLUDARABINE; FOSCARNET; GANCICLOVIR; MELPHALAN; METHYLPREDNISOLONE; VORICONAZOLE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL PROCEDURES; INFANT; MALE; MYCOSIS; OMENN SYNDROME; REDUCED INTENSITY CONDITIONING; SIBLING; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; INFANT; LYMPHOCYTES; MALE; SEVERE COMBINED IMMUNODEFICIENCY; SIBLINGS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 68849088494     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01020.x     Document Type: Article

References (25)

1. Corneo B, Moshous D, Gungo T, et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood 2001 : 97 : 2772 2776.
2. Omenn G. Familial reticuloendotheliosis with eosinophilia. N Engl J Med 1965 : 273 : 427 432.
3. Santagata S, Villa A, Sobacchi C, Cortes P, Vezzoni P. The genetic and biochemical basis of Omenn syndrome. Immunol Rev 2000 : 178 : 64 74.
4. Aleman K, Noordzij JG, De Groot R, Van Dongen JJ, Hartwig NG. Reviewing Omenn syndrome. Eur J Pediatr 2001 : 160 : 718 725.
5. Rieux-Laucat F, Bahadoran P, Brousse N, et al. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome. J Clin Invest 1998 : 102 : 312 321.
6. Wirt DP, Brooks EG, Vaidya S, Klimpel GR, Waldmann TA, Goldblum RM. Novel T-lymphocyte population in combined immunodeficiency with features of graft versus host disease. N Engl J Med 1989 : 321 : 370.
7. Cavadini P, Vermi W, Facchetti F, et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 2005 : 115 : 728 732.
8. Gomez L, Le Deist F, Blanche S, Cavazzana-Calvo M, Griscelli C, Fischer A. Treatment of Omenn syndrome by bone marrow transplantation. J Pediatr 1995 : 127 : 76 81.
9. Mazzolari E, Moshous D, Forino C, et al. Hematopoietic stem cell transplantation in Omenn syndrome: A single-center experience. Bone Marrow Transplant 2005 : 36 : 107 114.
10. Dalal I, Reid B, Doyle J Freedman M, Calderwood S, Saunders F, Roifman CM. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant 2000 : 25 : 613 621.
11. Loechelt BJ, Shapiro RS, Jyonouchi H, Filipovich AH. Mismatched bone marrow transplantation for Omenn syndrome: A variant of severe combined immunodeficiency. Bone Marrow Transplant 1995 : 16 : 381 385.
12. Rossi G, Zecca M, Giorgiani G, Bonetti F, De Stefano P, Locatelli F. Non-myeloablative stem cell transplantation for severe combined immunodeficiency - Omenn syndrome. Br J Haematol 2004 : 125 : 406 407.
13. Amrolia P, Gaspar HB, Hassan A, et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000 : 96 : 1239 1246.
14. Tomizawa D, Aoki Y, Nagasawa M, et al. Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome. Eur J Haematol 2005 : 75 : 441 444.
15. Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: Report of the European experience 1968-99. Lancet 2003 : 361 : 553 560.
16. Rizzo JD, Wingard JR, Tichelli A, et al. Recomended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendation of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Tranasplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant 2006 : 37 : 249 261.
17. Corradini P, Tarella C, Olivieri A, et al. Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remission in patients with poor-risk hematologic malignancies. Blood 2002 : 99 : 75 82.
18. Jimenez M, Ercilla G, Martinez C. Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Leukemia 2007 : 21 : 1628 1637.
19. Satwani P, Cooper N, Rao K, Amrolia P. Reduced intensity conditioning allogeneic stem cell transplantation in childhood malignant nonmalignant diseases. Bone Marrow Transplant 2008 : 41 : 173 182.
20. Bueno J, Ramil J, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatr Drugs 2002 : 4 : 279.
21. Castagnola E, Cappelli B, Erba B, Rabagliati A, Lanino E, Dini G. Cytomegalovirus infection after bone marrow transplantation in children. Hum Immunol 2004 : 65 : 416.
22. Gibel S, Maccario R, Lilleri D, et al. The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005 : 36 : 503 509. (Pubitemid 43118144)
23. Yakushiji K, Gondo H, Kamezaki K, et al. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: Comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant 2002 : 29 : 599 606.
24. Sprinter KL, Chou S, LI S, et al. How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. J Clin Microbiol 2005 : 43 : 208.
25. Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997 : 89 : 4531 4536.